These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
172 related items for PubMed ID: 24421304
1. Cost effectiveness of a pragmatic exercise intervention (EXIMS) for people with multiple sclerosis: economic evaluation of a randomised controlled trial. Tosh J, Dixon S, Carter A, Daley A, Petty J, Roalfe A, Sharrack B, Saxton JM. Mult Scler; 2014 Jul; 20(8):1123-30. PubMed ID: 24421304 [Abstract] [Full Text] [Related]
6. Economic evaluation of a brief education, self-management and upper limb exercise training in people with rheumatoid arthritis (EXTRA) programme: a trial-based analysis. Manning VL, Kaambwa B, Ratcliffe J, Scott DL, Choy E, Hurley MV, Bearne LM. Rheumatology (Oxford); 2015 Feb; 54(2):302-9. PubMed ID: 25173349 [Abstract] [Full Text] [Related]
7. Disease-Modifying Therapies for Relapsing-Remitting and Primary Progressive Multiple Sclerosis: A Cost-Utility Analysis. Zimmermann M, Brouwer E, Tice JA, Seidner M, Loos AM, Liu S, Chapman RH, Kumar V, Carlson JJ. CNS Drugs; 2018 Dec; 32(12):1145-1157. PubMed ID: 30141001 [Abstract] [Full Text] [Related]
10. Cost-effectiveness of a pragmatic exercise intervention for women with breast cancer: results from a randomized controlled trial. Gordon LG, DiSipio T, Battistutta D, Yates P, Bashford J, Pyke C, Eakin E, Hayes SC. Psychooncology; 2017 May; 26(5):649-655. PubMed ID: 27338125 [Abstract] [Full Text] [Related]
11. The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis. Ball S, Vickery J, Hobart J, Wright D, Green C, Shearer J, Nunn A, Cano MG, MacManus D, Miller D, Mallik S, Zajicek J. Health Technol Assess; 2015 Feb; 19(12):vii-viii, xxv-xxxi, 1-187. PubMed ID: 25676540 [Abstract] [Full Text] [Related]
12. An economic evaluation attached to a single-centre, parallel group, unmasked, randomized controlled trial of a 3-day intensive social cognitive treatment (can do treatment) in patients with relapsing remitting multiple sclerosis and low disability. van Mastrigt GA, Evers SM, Heerings M, Visser LH, Ruimschotel RP, Hussaarts A, Duyverman L, Valkenburg-Vissers J, Cornelissen J, Bos M, van Droffelaar M, Jongen PJ. J Med Econ; 2019 Oct; 22(10):967-980. PubMed ID: 31084442 [Abstract] [Full Text] [Related]
17. Pragmatic exercise intervention in people with mild to moderate multiple sclerosis: a randomised controlled feasibility study. Carter AM, Daley AJ, Kesterton SW, Woodroofe NM, Saxton JM, Sharrack B. Contemp Clin Trials; 2013 Jul; 35(2):40-7. PubMed ID: 23612222 [Abstract] [Full Text] [Related]
18. Cost-effectiveness of acupuncture care as an adjunct to exercise-based physical therapy for osteoarthritis of the knee. Whitehurst DG, Bryan S, Hay EM, Thomas E, Young J, Foster NE. Phys Ther; 2011 May; 91(5):630-41. PubMed ID: 21415230 [Abstract] [Full Text] [Related]
19. Cost-effectiveness of a national exercise referral programme for primary care patients in Wales: results of a randomised controlled trial. Edwards RT, Linck P, Hounsome N, Raisanen L, Williams N, Moore L, Murphy S. BMC Public Health; 2013 Oct 29; 13():1021. PubMed ID: 24164697 [Abstract] [Full Text] [Related]